Anand Patel

Very excited to share interim results of our IIT looking at TKI + Inotuzumab in newly-diagnosed Ph+ ALL at #ASH24! We found high rates of molecular remission & improved toxicity profile with separating dasatinib & InO cycles @DrWendyStock ash.confex.com/ash/2024/webpr…

Thanks to @UChicagoMed for highlighting our work on air pollutant exposure and AML in their article discussing environmental research! Link to article - uchicagomedicine.org/forefront/canc… Link to @BloodAdvances paper led by @andrewthepalmer - pubmed.ncbi.nlm.nih.gov/38810264/

Wishing everyone a joyous and luminous #Diwali. May this Festival of Lights brighten your life with happiness, peace, and prosperity. Let’s celebrate the triumph of light over darkness and hope over despair. 🪔✨ #HappyDiwali

Reminder about @HemeReports #ASH24 menin session on January 28th! Experts are @EuniceWangMD @jaltmanmd @GhayasIssa @Dr_AmerZeidan @LeukDocJZ @Daver_Leukemia Join me @sanamloghavi @KMirza @doctorpemm @NitinJainMD! x.com/i/spaces/1nAKE…

the next @HemeReports spaces event will be on January 28th on #ASH24 menin inhibitor in AML abstracts! We will have @EuniceWangMD @jaltmanmd @GhayasIssa @Dr_AmerZeidan @LeukDocJZ @Daver_Leukemia as experts! @sanamloghavi @KMirza @doctorpemm @NitinJainMD x.com/i/spaces/1nAKE…

join the @HemeReports crew for a spaces event tomorrow focused on #ASH24 CLL updates! @NitinJainMD @sanamloghavi @KMirza @doctorpemm @mshadman @DanilovLab @TaylorJ_MD @calliecoombsmd @dbranderMD x.com/i/spaces/1BRJj…

Proud to highlight 3 abstracts at #ASH24 from mentees! @LeahGoldberg20 - IDH1/2m MPN-AP/BP outcomes tinyurl.com/uxjkpury @andrewthepalmer - disparities in MF tinyurl.com/mr3t4522 @SamuelJYates - time to treatment w/ HMA + VEN in newly-dx AML

Happy to share my take on @VuMedi regarding the management of MPN-AP/BP! vumedi.com/video/current-…

Great to be at my alma mater @mumedicine to receive the Outstanding Young Physician Award - plus my parents were able to join me!

Election Day should be a national holiday. Pass it on.

Please consider voting for @SoniSmithMD! society.asco.org/about-asco/asc…

Our manuscript refining risk prediction for HMA+venetoclax-based treatment in AML is now out in @BloodJournal first edition! ashpublications.org/blood/article/…

👉👉👉Proposals for revised International Working Group–European LeukemiaNet criteria for #anemia response in myelofibrosis | ⁦@BloodJournal⁩ | #ASH24 ⁦@ASH_hematology⁩ | #MPNSM cc: ⁦@mtmdphd⁩ ashpublications.org/blood/article/…

Round 2! Got to talk about targeted therapies in MPNs and listen to an excellent talk on thrombosis in MPNs by Dr Nancy Delgado Lopez @ContactoAmeh #AMEH24

An honor to share a session with @DrMarcosdelima and Dr Raul Martinez focused on cellular therapy and novel therapies in ALL! @ContactoAmeh

What a beautiful location for the @ContactoAmeh meeting!

On my way to Veracruz for the @ContactoAmeh Annual Congress! Can't wait to talk about ALL management in older adults and targeted therapies in MPNs

Drs. @Anand_88_Patel and @RaajitRampal discuss the risk factors for progression to myeloproliferative neoplasms, potential early-intervention strategies, and considerations around the timing of allogeneic HSC transplantations. bit.ly/3Yp6Ke5

A comprehensive review in @BloodJournal on risk stratification/scoring in MPNs ashpublications.org/blood/article/…